Product Information

DEXMETHYLPHENIDATE ER 40 MG CP is a generic product labeled by Granules Pharmaceuticals Inc., priced at $1.9258 per EA under NDC 70010001101. Its NADAC has been published 289 times since Feb 10, 2021.

FDA first approved this application on Sep 9, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DEXMETHYLPHENIDATE ER 40 MG CP

DEXMETHYLPHENIDATE HYDROCHLORIDE
$1.9258per EA
DEA Schedule CII

Strength

40 mg/1

NDC

70010001101

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

6/10/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA213813

FDA Approved

9/9/2020

TE Code

AB

On Market Since

12/1/2020

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXMETHYLPHENIDATE ER 40 MG CP has been published 289 times since Feb 10, 2021, and over the history we have for it it has declined 47.0%. The table below summarizes its recorded NADAC range and movement.

Current price$1.9258 per EA
All-time high$4.0931 (Apr 14, 2021)
All-time low$0.9935 (Jul 17, 2024)
52-week high$1.9258
52-week low$1.2166
Median price$1.4934
Average price$1.6837
Largest weekly change-48.6% (Apr 21, 2021)
Weeks tracked289
Tracking sinceFeb 10, 2021

Price History

1W

0.0%

1M

0.0%

3M

+38.1%

6M

+19.1%

1Y

+24.2%

3Y

+29.0%

5Y

-18.4%

All

-47.0%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the DEXMETHYLPHENIDATE HYDROCHLORIDE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of DEXMETHYLPHENIDATE ER 40 MG CP?

The current National Average Drug Acquisition Cost (NADAC) for DEXMETHYLPHENIDATE ER 40 MG CP, manufactured by Granules Pharmaceuticals Inc., is $1.9258 per EA (NDC 70010001101), effective Aug 19, 2026.

How has the price of DEXMETHYLPHENIDATE ER 40 MG CP changed over time?

Over the history we have for it, the NADAC for DEXMETHYLPHENIDATE ER 40 MG CP has declined 47.0%. It has been tracked across 289 weekly CMS publications since Feb 10, 2021.

What are the highest and lowest recorded NADAC prices for DEXMETHYLPHENIDATE ER 40 MG CP?

Since Feb 10, 2021, the NADAC for DEXMETHYLPHENIDATE ER 40 MG CP has ranged from a low of $0.9935 (Jul 17, 2024) to a high of $4.0931 (Apr 14, 2021), with a median of $1.4934 per EA.

Are there cheaper alternatives to DEXMETHYLPHENIDATE ER 40 MG CP?

No other NADAC-published product currently shares the active ingredient and strength of DEXMETHYLPHENIDATE ER 40 MG CP in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures DEXMETHYLPHENIDATE ER 40 MG CP?

DEXMETHYLPHENIDATE ER 40 MG CP (NDC 70010001101) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.